TC Biopharm () (TCBPW)

0.01

-0.00 (-18.03%)

At close: Mar 04, 2025, 9:38 AM

TC Biopharm () Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Net Income	-5.91M	-1.31M	-13.58M	-5.46M	-6.07M
Depreciation & Amortization	633.01K	959.05K	1.01M	1.08M	904.47K
Stock-Based Compensation	444.46K	1.12M	n/a	804.71K	835.79K
Other Working Capital	863.31K	-762.15K	n/a	n/a	n/a
Other Non-Cash Items	-7.26M	-15.26M	7.58M	-1.58M	-2.66M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	1.54M	-799.65K	-591.62K	1.73M	258.05K
Operating Cash Flow	-10.54M	-15.29M	-5.58M	-3.43M	-6.73M
Capital Expenditures	-110.35K	-240.71K	-20.03K	-34.9K	-2.03M
Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-98.44K	-69.48K	-123.19K	-170.09K	-170.06K
Investing Cash Flow	-208.79K	-310.2K	-143.22K	-204.99K	-2.2M
Debt Repayment	n/a	-2.61M	6.26M	-415.27K	135.54K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	4.33M	17.9M	-21.16K	-53.27K	n/a
Financial Cash Flow	8.52M	18.65M	6.53M	3.43M	3.27M
Net Cash Flow	-2.35M	3.24M	818.67K	-208.48K	956.5K
Free Cash Flow	-10.66M	-15.53M	-5.6M	-3.47M	-8.76M